WRENTHAM, MA , June 26, 2015 (GLOBE NEWSWIRE) -- Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical device company specializing in the foot and ankle, today announced that registration is open for the 2015 Global Foot and Ankle Symposium (GFAS) to be held on December 4-5 in New York City, NY.
The GFAS is a cornerstone of Novastep’s medical education platform and is designed to alternate each year between European and North American venues. The Symposium features an agenda that is specifically focused on foot and ankle pathologies, with members of faculty recruited from both sides of the Atlantic. It is being co-chaired by Arthur K. Walling, M.D., Chairman of the A.O. North America foot and ankle courses since 1999 and Lowell Weil, Jr., DPM, FACFAS, internationally recognized educator and author of more than 50 scientific papers and book chapters. “This symposium will have a combination of expertise from leading foot and ankle surgeons. U.S. and European members of faculty will present their philosophies, procedures and outcomes that are geographically unique making this a meeting not to be missed. The format will be lecture and case controversy based on topics that are applicable to all foot and ankle surgeons which gives attendees the opportunity to really hear what specialists are doing in their day to day practices” said Weil.
In addition to the didactic sessions, participants will also have the opportunity to hear compelling point/counterpoint discussions and take part in practical, hands-on workshops. “Our primary objective in constructing this course is to offer the participants the most current treatment methods for an array of foot and ankle disorders.” explained Walling. “We have assembled a diverse group of foot and ankle surgeons so that they can explain ‘how they do it.’ With a combination of didactics, case presentations and labs, the participants should receive a world class experience.”
Follow Novastep and their key related events live on Twitter @InfoNovastep.
Novastep is a global medical device company specializing in the design, development and commercialization of advanced technologies that treat conditions affecting the foot and ankle. The Company is focused to optimize clinical efficiencies, inventory management and healthcare economics by transforming the way foot and ankle products are deployed and utilized in the surgical environment. Novastep has allied itself with a strategic network of key international opinion leaders to deliver breakthrough technologies, innovative services and compelling medical education programs to the foot and ankle community.
Novastep’s portfolio, services and distribution platforms are uniquely positioned to address foot and ankle trauma, deformity corrections and Charcot fracture management.
For further information concerning this announcement and/or Novastep, Inc., send all inquiries to email@example.com or call 877.287.0795.
Symposium registration is now open at: http://www.novasteportho.com